Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2019 1
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.
Vergoossen DLE, Plomp JJ, Gstöttner C, Fillié-Grijpma YE, Augustinus R, Verpalen R, Wuhrer M, Parren PWHI, Dominguez-Vega E, van der Maarel SM, Verschuuren JJ, Huijbers MG. Vergoossen DLE, et al. Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2020635118. doi: 10.1073/pnas.2020635118. Proc Natl Acad Sci U S A. 2021. PMID: 33753489 Free PMC article.
MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity.
Huijbers MG, Vergoossen DL, Fillié-Grijpma YE, van Es IE, Koning MT, Slot LM, Veelken H, Plomp JJ, van der Maarel SM, Verschuuren JJ. Huijbers MG, et al. Among authors: vergoossen dl. Neurol Neuroimmunol Neuroinflamm. 2019 Feb 21;6(3):e547. doi: 10.1212/NXI.0000000000000547. eCollection 2019 May. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 30882021 Free PMC article.
Enrichment of serum IgG4 in MuSK myasthenia gravis patients.
Vergoossen DLE, Ruiter AM, Keene KR, Niks EH, Tannemaat MR, Strijbos E, Lipka AF, van der Zijde ECJ, van Tol MJD, Bakker JA, Wevers BA, Westerberg E, Borges LS, Tong OC, Richman DP, Illa I, Punga AR, Evoli A, van der Maarel SM, Verschuuren JJ, Huijbers MG. Vergoossen DLE, et al. J Neuroimmunol. 2022 Oct 7;373:577978. doi: 10.1016/j.jneuroim.2022.577978. Online ahead of print. J Neuroimmunol. 2022. PMID: 36240543 Free article.
Food restriction does not relieve PTSD-like anxiety.
Hendriksen H, Bink DI, Vergoossen DL, Suzet van Slobbe E, Olivier B, Oosting RS. Hendriksen H, et al. Among authors: vergoossen dl. Eur J Pharmacol. 2015 Apr 15;753:177-82. doi: 10.1016/j.ejphar.2014.10.060. Epub 2014 Nov 22. Eur J Pharmacol. 2015. PMID: 25460029